Omnicell share price today

(OMCL)

Omnicell share price is $46.01 & ₹3,899.85 as on 14 Dec 2024, 2.30 'hrs' IST

$46.01

▲

0.05

(0.11%)

Market is closed - opens 8 PM, 16 Dec 2024

View live Omnicell share price in Dollar and Rupees. Guide to invest in Omnicell from India. Also see the sentimental analysis on Indian investors investing in Omnicell. Get details on the Indian mutual funds that are investing in Omnicell. Get Analyst recommendations and forecasts along with all the Omnicell's financials.

Omnicell share price movements

$44.46
$46.04
$46.01
3.37%
Downside
Day's Volatility :3.43%
Upside
0.07%
$25.12
$55.75
$46.01
45.4%
Downside
52 Weeks Volatility :54.94%
Upside
17.46%

Omnicell Returns

Period	Omnicell Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	2.54%	-9.7%	0.0%
6 Months	64.85%	-3.4%	0.0%
1 Year	23.29%	4.2%	0.0%
3 Years	-73.75%	4.2%	-18.1%

Omnicell Key Statistics

in dollars & INR

Previous Close	$45.96
Open	$45.48
Today's High	$46.04
Today's Low	$44.46
Market Capitalization	$2.2B
Today's Volume	$293.5K
52 Week High	$55.745
52 Week Low	$25.12
Revenue TTM	$1.1B
EBITDA	$26.5M
Earnings Per Share (EPS)	$-0.39
Profit Margin	-1.66%
Quarterly Earnings Growth YOY	0.56%
Return On Equity TTM	-1.46%

How to invest in Omnicell from India?

It is very easy for Indian residents to invest directly in Omnicell from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Omnicell stock in both rupees (INR) and dollars (USD). Search for Omnicell or OMCL on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Omnicell or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Omnicell shares which would translate to 0.018 fractional shares of Omnicell as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Omnicell

-15%

Period: Sep 15, 2024 to Dec 14, 2024. Change in 30 Days versus previous period

Search volume for Omnicell on INDmoney from India has reduced in the last 30 days as on Dec 15, 2024. -15% less investors are searching Omnicell in the last 30 days versus the previous period.

Global Institutional Holdings in Omnicell

BlackRock Inc
17.67%
Vanguard Group Inc
11.95%
State Street Corp
4.90%
Champlain Investment Partners, LLC
3.34%
Dimensional Fund Advisors, Inc.
2.69%
Pacer Advisors, INC.
2.69%

Analyst Recommendation on Omnicell

Buy

60%Buy

33%Hold

6%Sell

Based on 15 Wall street analysts offering stock ratings for Omnicell(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Omnicell

What analysts predicted

Upside of 22.33%

Current:

$46.01

Target:

$56.29

Insights on Omnicell

Price Movement
In the last 6 months, OMCL stock has moved up by 64.9%
Increasing Revenue
Revenue is up for the last 3 quarters, 246.15M → 282.42M (in $), with an average increase of 6.5% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -15.67M → 8.63M (in $), with an average increase of 288.2% per quarter
OMCL vs DOCS (1 yr)
In the last 1 year, Doximity, Inc. has given 96.8% return, outperforming this stock by 79.4%
OMCL vs DOCS (3 yr)
In the last 3 years, Omnicell Inc has experienced a drawdown of -74.4%, however Doximity, Inc. resisted the overall trend and outperformed by 72.4%
Price to Sales
ForOMCL every $1 of sales, investors are willing to pay $2.0, whereas for Doximity, Inc., the investors are paying $18.8 for every $1 of sales.

Omnicell Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$787.3M	↑ 9.93%
Net Income	$37.7M	↑ 83.11%
Net Profit Margin	4.79%	↑ 1.91%

	FY19	Y/Y Change
Revenue	$897.0M	↑ 13.94%
Net Income	$61.3M	↑ 62.58%
Net Profit Margin	6.84%	↑ 2.05%

	FY20	Y/Y Change
Revenue	$892.2M	↓ 0.54%
Net Income	$32.2M	↓ 47.51%
Net Profit Margin	3.61%	↓ 3.23%

	FY21	Y/Y Change
Revenue	$1.1B	↑ 26.88%
Net Income	$77.8M	↑ 141.81%
Net Profit Margin	6.88%	↑ 3.27%

	FY22	Y/Y Change
Revenue	$1.3B	↑ 14.48%
Net Income	$5.6M	↓ 92.74%
Net Profit Margin	0.44%	↓ 6.44%

	FY23	Y/Y Change
Revenue	$1.1B	↓ 11.48%
Net Income	$-20.4M	↓ 460.68%
Net Profit Margin	-1.78%	↓ 2.22%

	Q2 FY23	Q/Q Change
Revenue	$299.0M	↑ 2.87%
Net Income	$3.5M	↓ 123.01%
Net Profit Margin	1.15%	↑ 6.31%

	Q3 FY23	Q/Q Change
Revenue	$298.7M	↓ 0.1%
Net Income	$5.6M	↑ 60.91%
Net Profit Margin	1.86%	↑ 0.71%

	Q4 FY23	Q/Q Change
Revenue	$258.8M	↓ 13.33%
Net Income	$-14.4M	↓ 358.87%
Net Profit Margin	-5.55%	↓ 7.41%

	Q1 FY24	Q/Q Change
Revenue	$246.2M	↓ 4.9%
Net Income	$-15.7M	↑ 9.05%
Net Profit Margin	-6.37%	↓ 0.82%

	Q2 FY24	Q/Q Change
Revenue	$276.8M	↑ 12.45%
Net Income	$3.7M	↓ 123.83%
Net Profit Margin	1.35%	↑ 7.72%

	Q3 FY24	Q/Q Change
Revenue	$282.4M	↑ 2.03%
Net Income	$8.6M	↑ 131.06%
Net Profit Margin	3.06%	↑ 1.71%

	FY18	Y/Y Change
Profit	$372.3M	↑ 15.6%

	FY19	Y/Y Change
Profit	$436.9M	↑ 17.35%

	FY20	Y/Y Change
Profit	$413.3M	↓ 5.41%

	FY21	Y/Y Change
Profit	$554.7M	↑ 34.2%

	FY22	Y/Y Change
Profit	$589.0M	↑ 6.19%

	FY23	Y/Y Change
Profit	$496.8M	↓ 15.64%

	Q2 FY23	Q/Q Change
Profit	$134.4M	↑ 7.53%

	Q3 FY23	Q/Q Change
Profit	$132.0M	↓ 1.84%

	Q4 FY23	Q/Q Change
Profit	$105.4M	↓ 20.13%

	Q1 FY24	Q/Q Change
Profit	$95.3M	↓ 9.57%

	Q2 FY24	Q/Q Change
Profit	$114.4M	↑ 19.97%

	Q3 FY24	Q/Q Change
Profit	$122.3M	↑ 6.92%

	FY18	Y/Y Change
Operating Cash Flow	$104.0M	↑ 318.64%
Investing Cash Flow	$-54.4M	↑ 55.41%
Financing Cash Flow	$-13.6M	↑ 37.66%

	FY19	Y/Y Change
Operating Cash Flow	$145.0M	↑ 39.48%
Investing Cash Flow	$-61.7M	↑ 13.41%
Financing Cash Flow	$-23.5M	↑ 72.68%

	FY20	Y/Y Change
Operating Cash Flow	$185.9M	↑ 28.18%
Investing Cash Flow	$-279.9M	↑ 353.86%
Financing Cash Flow	$456.3M	↓ 2043.31%

	FY21	Y/Y Change
Operating Cash Flow	$231.8M	↑ 24.72%
Investing Cash Flow	$-412.5M	↑ 47.39%
Financing Cash Flow	$47.4M	↓ 89.62%

	FY22	Y/Y Change
Operating Cash Flow	$77.8M	↓ 66.45%
Investing Cash Flow	$-58.7M	↓ 85.78%
Financing Cash Flow	$-21.0M	↓ 144.24%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$72.9M	↑ 470.89%
Investing Cash Flow	$-14.8M	↑ 8.63%
Financing Cash Flow	$3.6M	↓ 6.71%

Omnicell Technicals Summary

Sell

Neutral

Buy

Omnicell is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Omnicell Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Omnicell Inc	0.74%	64.85%	23.29%	-73.75%	-42.56%
Solventum Corp	2.44%	27.33%	0.67%	0.67%	0.67%
Doximity, Inc.	0.19%	85.68%	93.83%	5.72%	-1.62%
Veeva Systems Inc.	-0.4%	27.28%	25.67%	-10.01%	58.18%
Ge Healthcare Technologies Inc.	-2.19%	4.58%	8.05%	34.07%	34.07%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Omnicell Inc	470.14	NA	2.28	1.68	-0.01	-0.01	NA	26.59
Solventum Corp	NA	NA	NA	6.26	0.17	0.08	NA	NA
Doximity, Inc.	60.57	60.57	2.42	0.9	0.19	0.12	NA	5.15
Veeva Systems Inc.	57.83	57.83	1.3	4.76	0.13	0.06	NA	28.8
Ge Healthcare Technologies Inc.	22.36	22.36	8.82	4.28	0.22	0.06	0.0	18.2

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Omnicell Inc	Buy	$2.2B	-42.56%	470.14	-1.66%
Solventum Corp	Hold	$10.8B	0.67%	NA	15.73%
Doximity, Inc.	Hold	$9.8B	-1.62%	60.57	33.69%
Veeva Systems Inc.	Buy	$38.0B	58.18%	57.83	23.91%
Ge Healthcare Technologies Inc.	Buy	$37.8B	34.07%	22.36	8.56%

About Omnicell

since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice

Organization	Omnicell
Employees	3660
CEO	Mr. Randall A. Lipps
Industry	Technology Services

Management People of Omnicell

Name	Title
Mr. Randall A. Lipps	Founder, Executive Chairman, President & CEO
Mr. Nchacha E. Etta	Executive VP & CFO
Mr. Corey J. Manley	Executive VP, Chief Legal & Administrative Officer and Corporate Secretary
Mr. Nnamdi Njoku	Executive VP & COO
Mr. Brian H. Nutt	VP, Chief Accounting Officer & Corporate Controller
Mr. Giri Chodavarapu	Senior VP & Chief Information Officer
Ms. Kathleen Nemeth	Senior Vice President of Investor Relations
Mr. Maximo Rocha	Senior VP & Chief People Officer
Ms. Minoo Mortazavi	Senior Vice President of Global Operations
Ms. Sara Dalmasso	Senior VP & GM of International

Important FAQs about investing in Omnicell from India :

What is Omnicell share price today?

Omnicell share price today stands at $46.01, Open: $45.48 ; Previous Close: $45.96 ; High: $46.04 ; Low: $44.46 ; 52 Week High: $55.75 ; 52 Week Low: $25.12. The stock opens at $45.48, after a previous close of $45.96. The stock reached a daily high of $46.04 and a low of $44.46, with a 52-week high of $55.75 and a 52-week low of $25.12.

Can Indians buy Omnicell shares?

Yes, Indians can invest in the Omnicell (OMCL) from India.

With INDmoney, you can buy Omnicell at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Omnicell at zero transaction cost.

How can I buy Omnicell shares from India?

It is very easy to buy Omnicell from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Omnicell be purchased?

Yes, you can buy fractional shares of Omnicell with INDmoney app.

What are the documents required to start investing in Omnicell stocks?

To start investing in Omnicell, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.